208 related articles for article (PubMed ID: 31082487)
1. Multicentre study to determine the Etest epidemiological cut-off values of antifungal drugs in Candida spp. and Aspergillus fumigatus species complex.
Salsé M; Gangneux JP; Cassaing S; Delhaes L; Fekkar A; Dupont D; Botterel F; Costa D; Bourgeois N; Bouteille B; Houzé S; Dannaoui E; Guegan H; Charpentier E; Persat F; Favennec L; Lachaud L; Sasso M
Clin Microbiol Infect; 2019 Dec; 25(12):1546-1552. PubMed ID: 31082487
[TBL] [Abstract][Full Text] [Related]
2. Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method.
Espinel-Ingroff A; Arendrup M; Cantón E; Cordoba S; Dannaoui E; García-Rodríguez J; Gonzalez GM; Govender NP; Martin-Mazuelos E; Lackner M; Lass-Flörl C; Linares Sicilia MJ; Rodriguez-Iglesias MA; Pelaez T; Shields RK; Garcia-Effron G; Guinea J; Sanguinetti M; Turnidge J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799206
[TBL] [Abstract][Full Text] [Related]
3. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
4. Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent
Espinel-Ingroff A; Sasso M; Turnidge J; Arendrup M; Botterel F; Bourgeois N; Bouteille B; Canton E; Cassaing S; Dannaoui E; Dehais M; Delhaes L; Dupont D; Fekkar A; Fuller J; Garcia-Effron G; Garcia J; Gonzalez GM; Govender NP; Guegan H; Guinea J; Houzé S; Lass-Flörl C; Pelaez T; Forastiero A; Lackner M; Magobo R
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0109321. PubMed ID: 34370582
[TBL] [Abstract][Full Text] [Related]
5. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
7. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds.
Espinel-Ingroff A; Turnidge J
Rev Iberoam Micol; 2016; 33(2):63-75. PubMed ID: 27296911
[TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibility testing results of New Zealand yeast isolates, 2001-2015: Impact of recent CLSI breakpoints and epidemiological cut-off values for Candida and other yeast species.
Morris AJ; Rogers K; McKinney WP; Roberts SA; Freeman JT
J Glob Antimicrob Resist; 2018 Sep; 14():72-77. PubMed ID: 29486358
[TBL] [Abstract][Full Text] [Related]
9. Gradient concentration strip-specific epidemiological cut-off values of antifungal drugs in various yeast species and five prevalent Aspergillus species complexes.
Mercier V; Letscher-Bru V; Bougnoux ME; Delhaes L; Botterel F; Maubon D; Dalle F; Alanio A; Houzé S; Dannaoui E; Cassagne C; Cassaing S; Durieux MF; Fekkar A; Bouchara JP; Gangneux JP; Bonhomme J; Dupont D; Costa D; Sendid B; Chouaki T; Bourgeois N; Huguenin A; Brun S; Mahinc C; Hasseine L; Le Gal S; Bellanger AP; Bailly E; Morio F; Nourrisson C; Desbois-Nogard N; Perraud-Cateau E; Debourgogne A; Yéra H; Lachaud L; Sasso M
Clin Microbiol Infect; 2023 May; 29(5):652.e9-652.e15. PubMed ID: 36509375
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
Mallié M; Bastide JM; Blancard A; Bonnin A; Bretagne S; Cambon M; Chandenier J; Chauveau V; Couprie B; Datry A; Feuilhade M; Grillot R; Guiguen C; Lavarde V; Letscher V; Linas MD; Michel A; Morin O; Paugam A; Piens MA; Raberin H; Tissot E; Toubas D; Wade A
Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
[TBL] [Abstract][Full Text] [Related]
11. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
12. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
[TBL] [Abstract][Full Text] [Related]
13. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
Pfaller MA; Carvalhaes C; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015043
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Dannaoui E; Garcia-Effron G; Guinea J; Kidd S; Pelaez T; Sanguinetti M; Meletiadis J; Botterel F; Bustamante B; Chen YC; Chakrabarti A; Chowdhary A; Chryssanthou E; Córdoba S; Gonzalez GM; Guarro J; Johnson EM; Kus JV; Lass-Flörl C; Linares-Sicilia MJ; Martín-Mazuelos E; Negri CE; Pfaller MA; Tortorano AM
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437624
[TBL] [Abstract][Full Text] [Related]
15. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2011 Feb; 49(2):630-7. PubMed ID: 21159940
[TBL] [Abstract][Full Text] [Related]
16. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
[TBL] [Abstract][Full Text] [Related]
17. Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
Espinel-Ingroff A; Arendrup MC; Pfaller MA; Bonfietti LX; Bustamante B; Canton E; Chryssanthou E; Cuenca-Estrella M; Dannaoui E; Fothergill A; Fuller J; Gaustad P; Gonzalez GM; Guarro J; Lass-Flörl C; Lockhart SR; Meis JF; Moore CB; Ostrosky-Zeichner L; Pelaez T; Pukinskas SR; St-Germain G; Szeszs MW; Turnidge J
Antimicrob Agents Chemother; 2013 Dec; 57(12):5836-42. PubMed ID: 24018263
[TBL] [Abstract][Full Text] [Related]
18. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?].
Turan D; Aksaray S
Mikrobiyol Bul; 2022 Jul; 56(3):493-505. PubMed ID: 35960240
[TBL] [Abstract][Full Text] [Related]
19. Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital.
Posteraro B; Spanu T; Fiori B; De Maio F; De Carolis E; Giaquinto A; Prete V; De Angelis G; Torelli R; D'Inzeo T; Vella A; De Luca A; Tumbarello M; Ricciardi W; Sanguinetti M
Antimicrob Agents Chemother; 2015 Jul; 59(7):3944-55. PubMed ID: 25896705
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of Clinical Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) broth microdilution methods for determining the susceptibilities of Candida isolates].
Dalyan Cilo B; Topaç T; Ağca H; Sağlam S; Efe K; Ener B
Mikrobiyol Bul; 2018 Jan; 52(1):35-48. PubMed ID: 29642828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
